Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News OS Therapies Incorporated OSTX

Healthcare Biotechnology
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide... see more

Current News (NYSEAM:OSTX)

OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program to Advance Breakthrough Osteosarcoma Immunotherapies

Newsfile 3 days ago

OS Therapies Initiates US FDA BLA Filing for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

Newsfile 5 days ago

OS Therapies Announces Positive Biomarker Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

Newsfile January 15, 2026

OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary

Newsfile January 14, 2026

OS Therapies Enters into Warrant Inducement Agreements

Newsfile January 12, 2026

OS Therapies Provides First Half 2026 Corporate Outlook

Newsfile January 5, 2026

OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

Newsfile December 15, 2025

OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

Newsfile December 9, 2025

OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility

Newsfile December 5, 2025
View More News ››

Opinion & Analysis (NYSEAM:OSTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:OSTX)

OSTX....meh....float too large

No position
Iseneschal - October 10, 2025

OSTX....Looks like the Pump is Primed

GLTA
Iseneschal - October 10, 2025

OSTX.....early a.m NR $2.30

OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the...
Iseneschal - October 10, 2025

OSTX.....NR this a.m

On watch Looks like they want to raise money ; ) Gotta churn it ....to earn it....to burn it .....$1.85
Iseneschal - June 24, 2025

Using technical analysis for this one.

It is doing really well for shareholders
coolfooldumbguy - February 14, 2025

Buy buddy buy because it's taking off this morning.

It's time for you guys out there to be getting on board with this stock because it will be going up today,so good luck to all of you...
coolfooldumbguy - January 15, 2025
View more Bullboard ››

Osisko Development Corp.

Osisko Development Corp.

Osisko Development Corp. is a continental North American gold development company focused on past-producing mining camps ...
View More »

Podcasts